Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Nov 7;44(3):487–497. doi: 10.1097/IAE.0000000000003980

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the Opthalmic Communications Society, Inc.

This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.

PMC Copyright notice

Fig. 3. — Photobiomodulation improves BCVA in early/intermediate stage dry AMD. A. Subjects received PBM or Sham treatment at baseline, Month 4, Month 8 and Month 12 time points. Significant improvements in BCVA were observed through Month 13 following PBM treatment. B. At Month 13, nonstudy eyes showed a mean letter loss of 2.3 letters, Sham-treated eyes showed a mean letter gain of 3.0 letters, and PBM-treated eyes showed a mean letter gain of 5.4 letters. *Within-group (PBM) comparison, P < 0.005, ^PBM versus sham between-group comparison, P < 0.05. BL, baseline; M, month.